Session Details

U008 Laser and Device-based Treatment of Scars

Fri, Mar 7, 7:30 AM - 8:30 AM
W307A
1 CME Available Focus Session
View Map

DESCRIPTION

This session will explore the use of lasers and device-based technology to treat different types of scars. Traditional and cutting-edge techniques will be explored for the correction of erythematous, pigmented, hypertrophic and atrophic scars, acne scars, burn scars, surgical scars and complex scars from trauma. Session format will include lectures and panel discussion.

LEARNING OBJECTIVES

1.

Categorize scar types.

2.

Identify new devices and techniques for treating scars.

3.

Use an algorithmic approach to choose the most appropriate therapies for different scar types.

SCHEDULE

7:30 AM

Introduction

Arielle N.B. Kauvar, MD, FAAD

7:32 AM

Instrumentation, Scar Type and Skin Type

Kristen Marie Kelly, MD, FAAD

7:44 AM

Surgical and Trauma Scars

Arielle N.B. Kauvar, MD, FAAD

7:56 AM

Acne Scar Treatment

Girish S. Munavalli, MD, MHS, FAAD

8:08 AM

Burn and Trauma Scar Innovations

Jill S. Waibel, MD, FAAD

8:20 AM

Discussion / Q & A

DIRECTOR

Arielle N.B. Kauvar, MD, FAAD

Arielle N.B. Kauvar, MD, FAAD

SPEAKERS

Kristen Marie Kelly, MD, FAAD

Kristen Marie Kelly, MD, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

DISCLOSURES

Arielle N.B. Kauvar, MD, FAAD

Candela Corporation – Investigator(Grants/Research Funding); Lumenis – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding);

Kristen Marie Kelly, MD, FAAD

BioPhotas Inc. – Investigator(Grants/Research Funding); Candela Corporation – Investigator(Grants/Research Funding), Other(Equipment); Cutera – Other(Equipment); Lutronic – Investigator(Equipment), Investigator(Grants/Research Funding); Michelson Diagnostics – Investigator(Grants/Research Funding); NobelPharma – Consultant (1099 relationship)(Honoraria); Primus Pharmaceuticals – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Reliant Technologies, Inc. – Other(Equipment); Sciton Inc. – Investigator(Equipment); Sciton, Inc. – Consultant(Honoraria); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Thermage – Other(Equipment);

Girish S. Munavalli, MD, MHS, FAAD

AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);